Prostate MRI now carries pre-biopsy triage, biopsy guidance, staging, active surveillance, focal therapy planning and recurrence assessment. Image quality determines whether any of that is reliable: poor-quality studies detect less cancer, generate more equivocal PI-RADS 3 assessments, compromise staging and longitudinal comparison, and erode referrer confidence in the whole MRI-directed pathway.
PI-QUAL, the Prostate Imaging Quality system, began as a research quality-control tool built on PRECISION trial data and has been refined by the European Society of Urogenital Radiology into a version usable on both multiparametric and biparametric studies. This multi-author review proposes the implementation path rather than the score itself: multidisciplinary training, a retrospective audit of existing studies, protocol optimisation on the back of what the audit shows, structured reporting that carries the quality score, quality dashboards, local benchmarks, and AI tools where they help.
What makes this a practice-changer rather than a framework is the audit step. Most departments have no idea what proportion of their prostate studies are diagnostically adequate, and a PI-RADS 3 rate is usually attributed to biology rather than to a diffusion sequence that is not fit for purpose. Score a consecutive run of studies, see where the failures cluster - almost always a specific sequence on a specific scanner - and fix that. In a setting where scanner time and expertise are the binding constraints, this is the cheapest available improvement in prostate cancer detection: better use of the scans already being done.
- Audit a consecutive run of prostate MRI studies with PI-QUAL before changing anything
- Expect failures to cluster by sequence and scanner rather than by radiologist
- Carry the quality score in the structured report so referrers can weigh the result
- Review your PI-RADS 3 rate as a possible quality signal, not only a biological one
- Optimise the protocol against the audit findings, then re-audit rather than assume improvement
Why it matters
An equivocal prostate MRI is routinely blamed on the tumour when it is often the sequence, and nobody finds out without scoring the studies.
Don't overread it
This is a review proposing an implementation pathway; it does not itself show that adopting PI-QUAL improves cancer detection.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for radiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free